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GEFThe precise mechanisms viawhich Rac1 is activated by cadherin junctions are not fully known. In keratinocytes
Rac1 activation by cadherin junctions requires EGFR signalling, but how EGFR does so is unclear. To address
which activator could mediate E-cadherin signalling to Rac1, we investigated EGFR and two Rac1 GEFs, SOS1
and DOCK180. EGFR RNAi prevented junction-induced Rac1 activation and led to fragmented localization of
E-cadherin at cadherin contacts. In contrast, depletion of another EGFR family member, ErbB3, did not interfere
with either process. DOCK180 RNAi, but not SOS1, prevented E-cadherin-induced Rac1 activation. However, in a
strong divergence from EGFR RNAi phenotype, DOCK180 depletion did not perturb actin recruitment or
cadherin localisation at junctions. Rather, reduced DOCK180 levels impaired the resistance to mechanical
stress of pre-formed cell aggregates. Thus, within the same cell type, EGFR and DOCK180 regulate Rac1
activation by newly-formed contacts, but control separate cellular events that cooperate to stabilise
junctions.
© 2015 The Authors. Published by Elsevier Inc. This is an open access article under the CC BY-NC-ND license
(http://creativecommons.org/licenses/by-nc-nd/4.0/).1. Introduction
E-cadherin is the classical prototype cell–cell adhesion receptor.
The E-cadherin knockout is embryonic lethal, and thus its function is
critical for life. In homeostasis, the dynamic regulation of E-cadherin
signalling is fundamental for the differentiation, maintenance and
functional integrity of epithelia. Among thedifferent pathways activated
by E-cadherin contacts is the Rac1 small GTPase (hereafter referred to
as Rac). Rac plays an essential role in the differentiation of epithelial
organs by regulating polarization [1], lumen formation or epidermal
barrier integrity [2]. In addition to other functions in epithelia, Rac
stabilizes cell–cell contacts via regulation of E-cadherin trafﬁcking and
actin recruitment to junctions [1,3].
A major drive has been in place to identify how the engagement of
E-cadherin at contacts is able to activate Rac. Speciﬁc Rac activators or
guanine nucleotide exchange factors (GEF) [4] such as Tiam1 or Asef
have been reported to regulate adherens junctions in epithelial cells
[3]. However, their regulation of Rac activation upon junction assembly
has not been determined. More recently, ELMO2, an adaptor for the
unconventional GEFs of the DOCK family [5], has been identiﬁed as a
junction regulator in a genome-wide screen in Drosophila [6]. Depletion
of ELMO2 signiﬁcantly reduces Rac levels at newly formed contacts and).
l Research Ofﬁce, London, UK.
. This is an open access article underprevents the transient recruitment of DOCK180 to MDCK junctions [7].
However, the direct effect of DOCK180 RNAi on Rac activation could
not be evaluated in MDCK cells [7].
The variety of regulators identiﬁed to date imply two important points.
First, it is clear from current studies that distinct epithelial cell types em-
ploy distinct signalling mechanisms downstream of E-cadherin contacts
[3]. A prediction is that alternative GEFs may be involved in multiple cell
types to modulate cadherin signalling to Rac. Second, in the same cell
type, different GEFs could activate Rac locally at cell–cell contacts at differ-
ent time points and regulate distinct cellular events. Indeed, the number of
Rac-dependent cellular processes known to stabilise junctions strongly
suggests that, within the same cell type, various mechanisms modulate
GTPase signalling. Thus, there is a large scope to identify Rac regulators
and cellular mechanisms triggered by cadherin engagement.
These considerations led us to investigate in a single cell type the
potential ways in which new cadherin contacts activate Rac and the
speciﬁc functional outcome during junction stabilisation. In normal
keratinocytes, cell–cell adhesion-dependent activation of Rac requires
Epidermal Growth Factor Receptor (EGFR) [8]. EGFR signalling plays
an essential role in epithelia. EGFR−/− mice die soon after birth with
growth retardation, epithelial immaturity and dysfunction of multiple
organs [9,10]. E-cadherin contacts can utilise EGFR signalling to regulate
the assembly of adhesive structures [11,12] and activate speciﬁc path-
ways required for epithelial function, proliferation and survival [8,13,
14]. This crosstalk represents a fundamental principle via which differ-
ent cadherin receptors trigger signalling pathways in a cell type- and
growth factor receptor-speciﬁc manner [15–17].the CC BY-NC-ND license (http://creativecommons.org/licenses/by-nc-nd/4.0/).
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stimulation to regulate cell motility and other processes [18]. In the
context of cell–cell adhesion, it is likely that Rac may participate at least
in some of the cellular processes downstream of the EGFR–E-cadherin
cross-talk. We hypothesise that different Rac GEFs may participate
in junction stabilisation downstream and/or independently of EGFR.
Here we set out to dissect the mechanisms of Rac activation by new
cadherin contacts in keratinocytes. We sought to identify: (i) which
EGFR family members (EGFR, ErbB2, ErbB3 or ErbB4) can mediate
E-cadherin signalling to Rac and (ii) the potential involvement of the
Rac GEFs, SOS1 and DOCK180. SOS1 is a Ras and Rac dual exchange
factor [19] and is activated following EGF treatment [20]. DOCK180
activates Rac upon growth factor stimulation leading to migration,
integrin adhesion and cell protrusion [21,22]. DOCK180 also modulates
a variety of Rac-dependent events such as cell fusion during muscle
differentiation, migration of gonad cells in Drosophila and phagocytosis
of apoptotic cells and IgG opsonised particles [5]. We investigated
whether DOCK180 or SOS1 could facilitate cadherin-dependent activa-
tion of Rac, whether they operate downstream of EGFR and which
cellular event is regulated.
2. Materials and methods
2.1. Cell culture and treatment
Normal human keratinocytes from neonatal foreskin (strain Sf,
passages 3 to 7) were cultured on a mitomycin C (Sigma)-treated
monolayer of 3T3 ﬁbroblasts and cultures, in the absence of calcium-
dependent cell–cell contacts, were grown as described [23]. Cell–cell
contacts in conﬂuent cultures were induced by addition of calcium ions
(1.8 mM), rather than switching medium. For siRNA experiments, cells
were grown to 90% conﬂuence in low calciummedium and then treated
as described below. Conﬂuent cells were transfected with siRNA oligos
and RNAifect (Qiagen) or INTERFERin (Peqlab) as per manufacturer's
instructions.
Aggregation assays were performed essentially as described [24].
Conﬂuent keratinocytes were trypsinised in 500 μl trypsinisation
buffer (60% versene (v/v), 0.1% trypsin, 0.1 mM CaCl2) to prevent
cleavage of cadherins. Six drops of cell suspension per sample
(20 μl of 5 × 104 cells/ml in standard calcium medium) were pipetted
onto the inverted lid of a Petri dish and aggregates allowed to form in
a humid chamber. After 120 min, cells were pipetted gently (tritura-
tion) to disaggregate.
For bead assays, polystyrene beads (15 μm, Polysciences) were
coated with anti-E-cadherin antibody (HECD1) or heat inactivated
BSA overnight at 4 °C as described previously [8,23]. Recruitment of
DOCK180 or F-actin to E-cadherin clustered around latex beads for 15
or 30 min was performed as described [23].
2.2. Biochemistry
Following RNAi transfections, cellswerewashed twicewith cold PBS
and lysed in cold buffer (50 mM Tris–HCl pH 7.5, 1% Triton-X100,
150 mM NaCl, 0.1% SDS, 5 μg/ml leupeptin, 5 μg/ml pefabloc, 5 μg/ml
pepstatin, 50mMphenylmethylsulfonyl ﬂuoride). For standardWestern
blots of lysates, protein concentration was measured with the BCA
method (Pierce) using BSA as a standard. Equal amount of protein
was separated by SDS–PAGE and transferred onto a polyvinylidene
diﬂuoride membrane (PVDF) membrane (Millipore). Incubation with
primary antibodies was carried out overnight, and after incubation
with secondary antibodies blots were developed with ECL™ or ECL
Plus™ chemiluminescence and exposed to Hyperﬁlm ECL (all from GE
Healthcare).
E-cadherin tail and DOCK180 interaction was determined by in-
ducing cell–cell contacts for up to 30 min; cells were then lysed
(20 mM Hepes pH 7.5, 300 mM NaCl, 1% triton, 5 mM MgCl2, 1 mMDTT, 5 μg/ml leupeptin, 5 μg/ml pefabloc, 5 μg/ml pepstatin, 50 mM
phenylmethylsulfonyl ﬂuoride, 20 mM sodium ﬂuoride). The lysate was
added to either GST–E-cadherin beads (Glutathione sepharose, GE
Healthcare) or GST alone and incubated for 1 h at 4 °C, washed in lysis
buffer, resuspended in sample buffer and the whole sample separated
on SDS–PAGE.
2.3. Antibodies, immunoﬂuorescence and microscopy
The following primary antibodies were used against: EGFR (1005;
Santa Cruz); ErbB2 (CB11; Serotec); ErbB3 (C17; Santa Cruz); α3-integrin
(VM2; gift from F. Watt); E-cadherin (HECD1); α-catenin (VB1);
β-catenin (VB2); β1-integrin (gift from F Giancotti); DOCK180 (C19 and
H70; Santa Cruz); SOS1 (E1; Santa Cruz); actin (C4; MP Biomedicals);
β-tubulin (Tub2.1; Sigma); Rac1 (23A8; Millipore, Upstate); RhoA
(26C4; Santa Cruz); and Cdc42 (44; Transduction Laboratories). Sec-
ondary antibodies (ﬂuorescent and HRP conjugates) were bought
from DAKO.
Cells were ﬁxed in 3% PFA for 10 min, washed in PBS and
permeabilised with 0.1% Triton X-100 for 10 min at room temperature
[23]. For E-cadherin and staining, keratinocytes on coverslips were
imaged using a Leica DCS NT confocal microscope with Leica LCS Lite
software. Z-slices of 0.2 μm were taken. Z-slices were summed and
images were processed using open source ImageJ software.
For aggregation assays, phase contrast imageswere taken before and
after mechanical trituration of aggregates using an Olympus CKX41
microscope anda ColourView IIIu camera linked to Sort Imaging System
software. For bead assays, images were collected using a Zeiss Axiovert
200 microscope with Velocity software.
2.4. Immunoprecipitations
Cells were induced to form cell–cell contacts for 30 min and then
lysed in lysis buffer (1% Triton X-100, 15% Glycerol, 50 mM Tris–HCl
pH8, 150mMNaCl, and 5mMEDTA, 5 μg/ml leupeptin, 5 μg/ml pefabloc,
5 μg/ml, pepstatin, 50 mM phenylmethylsulfonyl ﬂuoride, 20 mM
sodium ﬂuoride, 1 mM sodium pyruvate, 1 mM sodium orthovanadate
and 20 mM β-glycero-phosphate). After centrifugation for 5 min, pre-
cleared supernatants were immunoprecipitated for 1 h with 5 μl of
the indicated antibody bound to 40 μl slur of protein A or protein
G-Sepharose-4B beads (Sigma). Beads were washed three times in lysis
buffer and SDS–PAGE sample buffer added to beads.
2.5. Reverse transcription polymerase chain reaction (RT-PCR)
Extraction of mRNA from cells grown in standard or low calcium
media was carried out using the GTC method. A SuperScript t™Π
Reverse Transcriptase (Invitrogen) reaction was performed with 1 μg
total mRNA, according to themanufacturer's protocol and using speciﬁc
PCR primers to amplify each family member: EGFR, (683 bp product);
ErbB2 (193 bp); ErbB3 (603 bp) and ErbB4 (718 bp). PCR products
were resolved on a 1% (w/v) agarose gel.
2.6. Quantiﬁcation
The area of each aggregate remaining after triturationwasmeasured
(excluding clusters smaller than 3 cells) and the average size of clusters
was calculated per sample. Values were expressed relative to control
cells. The intensity of relevant bands obtained in Western blots was
measured in the linear range, and values were corrected for control.
For bead assays, the percentage of attached beads with an enrich-
ment of DOCK180 or F-actin immunoﬂuorescence was quantiﬁed per
image; recruitment of DOCK180 to BSA coated-beads was done as
control.
For analysis of DOCK180 distribution at junctions, the E-cadherin
image was thresholded to leave only junctional E-cadherin and the
1907J.C. Erasmus et al. / Cellular Signalling 27 (2015) 1905–1913area remaining was measured in pixels. The thresholded E-cadherin
image was made into a binary mask and subtracted from the DOCK180
image to obtain DOCK180 that localizes at junctions. Junctional
DOCK180 was further thresholded and pixel area was measured. For
all channels, the percent area remaining after thresholding was calcu-
lated by dividing the thresholded pixel area by the raw image pixel
area. Two to four images were analysed per time-point, per sample
and per experiment. Three experiments were analysed. Mean, standard
deviation and statistical analysis (Unpaired Student t-test assuming
unequal variances) were calculated using pooled data from allA
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3. Results
3.1. EGFR, but not other family members, co-precipitates with E-cadherin
and participates in junction-dependent Rac activation
We and others have previously shown that EGFR co-precipitates
with E-cadherin receptors [13] and that the EGFR kinase activity isTime (min):siRNA:
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1908 J.C. Erasmus et al. / Cellular Signalling 27 (2015) 1905–1913required for Rac activation following E-cadherin contact formation [8].
However, EGFR family members can form homo- and heterodimers,
and it is not clear whether all family members are able to interact
with E-cadherin. Out of the four different EGFR family members, EGFR,
ErbB2 and ErbB3 are expressed in normal keratinocytes [25] as con-
ﬁrmed in this study (Figs. 1A, S1). From these, only EGFR was able
to co-precipitate with E-cadherin when cell–cell junctions are initi-
ated for 30 min (Fig. 1A). As a positive control, α3β1 integrin also
precipitated with EGFR, but not ErbB2 or ErbB3. These results indicate
that, when cell–cell junctions are formed, EGFR monomers or homo-
dimers, but not other EGFR family members, may co-cluster with
E-cadherin.
Pharmacological inhibition of EGFR kinase activity prevents Rac
activation upon junction assembly [8]; however, EGFR depletion has
not been previously examined to support the speciﬁcity of Rac activation
via this family member. To examine these points, we performed siRNA
to deplete EGFR and as a control ErbB3, which does not co-precipitate
with cadherin receptors. Depletion of EGFR or ErbB3 did not change
the levels of different EGFR family members, Rho GTPases or proteins
found in cadherin complexes (Fig. 1B–C). Upon junction formation,
Rac activation was signiﬁcantly increased in controls (scrambled or
ErbB3 depleted; Fig. 1D, G). In the absence of EGFR, this signiﬁcant
change in Rac∙GTP levels following cell–cell contact assembly was
abolished (Fig. 1F). In contrast, when ErbB3 was depleted, the increased
levels of Rac∙GTP induced by junctionswere similar to controls (Fig. 1G–I).
Both EGFR and ErbB3 are able to activate Rac upon ligand stimulation. Yet,
our data strongly indicates that, in the context of ligand-independent
junction assembly, there is a speciﬁc requirement for EGFR for Rac activa-
tion and ErbB3 cannot regulate cadherin-dependent Rac activation.
Strikingly, despite defective Rac activation upon EGFR depletion,
junction assembly was not completely abolished (Fig. 2A–B). However,
junctions were not uniformly stable: E-cadherin staining was frag-
mented, not covering the whole extension of each cell–cell contact
(Fig. 2A, C, D). In contrast, treatment with ErbB3 or scramble oligos
did not impair cadherin localization at junctions (Fig. 2A, D). Thus, Rac
signalling downstream of EGFR is necessary for junction maintenance,
rather than assembly of new cell–cell contacts.A
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Scale bar = 40 μm. *, p b 0.05.3.2. Identiﬁcation of putative GEFs necessary for Rac activation
It is feasible that E-cadherin–EGFR complexes could recruit and/or
activate a Rac-speciﬁc GEF directly or indirectly. We tested whether
two Rac exchange factors, SOS1 andDOCK180, could activate Rac down-
stream of EGFR signalling following junction induction. SOS1 and
DOCK180 can activate Rac in vitro and have been shown to regulate
Rac in vivo downstream of distinct cellular functions [18,19].
DOCK180 RNAi in keratinocytes did not reduce SOS1 protein levels
or vice versa (Fig. 3A–B) nor interfered with the levels of proteins in
the cadherin complex or Rho small GTPases (Fig. 3C–D). When
keratinocyte cell–cell contacts were initiated for 30 min, Rac∙GTP levels
increased signiﬁcantly following treatment with control or SOS1 siRNA
oligos (Fig. 3G–H). However, cells with reduced DOCK180 protein had
no signiﬁcant increase in active Rac levels (Fig. 3E–F). Thus, DOCK180,
but not SOS1, is likely to be one of the GEFs responsible for Rac activa-
tion by new junctions in keratinocytes. Our results suggest a selectivity
among distinct GEFs via which Rac is activated upon engagement of
cadherin receptors at cell–cell contacts. Our data is also supported by
a previous report on depletion of ELMO2 in MDCK and indicates that
DOCK180 may be important for junction signalling in cell types other
than keratinocytes. DOCK180 was not formally tested in MDCK cells
because of toxicity caused by its depletion. However, in contrast to
MDCK cells [7], DOCK180 RNAi did not reduce keratinocyte cell viability
(data not shown) and could be tested herein.
3.3. Mechanisms downstream of DOCK180 and EGFR to stabilise cadherins
at junctions are distinct
We tested whether DOCK180 is found at keratinocyte cell–cell con-
tacts in a time course from early to more mature contacts. E-cadherin
receptors are recruited to newly formed keratinocyte junctions as
early as 5 min and by 30 min, junction assembly, cytoskeletal reorgani-
zation and cell polarization are mostly complete [26,27]. In the absence
of cell adhesion, endogenousDOCK180was found dispersed in the cyto-
plasm (Fig. 4A). Upon addition of calcium ions, a pool of DOCK180 was
clearly recruited to the junctional region (Fig. 4A–B). This re-localizationsiRNA: con EGFRE3
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1909J.C. Erasmus et al. / Cellular Signalling 27 (2015) 1905–1913was signiﬁcant and increased with time. This result is in contrast to
the transient DOCK180 recruitment to MDCK new junctions (2.5 h),
but absent at more established contacts (5 h) [7].
In addition, clustering of cadherin receptors is sufﬁcient to recruit
DOCK180 to cadherins without a need for other adhesion receptors
found at junctions (Fig. 4C). Counterintuitively we found that DOCK180
localisation on cadherin clusters was not perturbed in the absence
of EGFR (Fig. 4D). Thus, even though Rac activation by junctions requires
both EGFR and DOCK180 (Figs. 1 and 3), the ability of DOCK180 to be
enriched at cell–cell contacts is EGFR-independent.
This potential association between DOCK180-E-cadherin receptors
was conﬁrmed by biochemical experiments. In the absence of junctions,
DOCK180 was already found in complexes with GST–E-cadherin tail,and remained associated for up to 30 min of junction assembly (Fig. 4E).
Depletion of EGFR did not alter the interaction of DOCK180-cadherin
complexes (Fig. 4F). We concluded that DOCK180 is associated with
cadherin receptors at steady-state and this could explain the reason why
further DOCK180 recruitment to cell–cell contacts is not modulated by
EGFR.
3.4. DOCK180 and EGFR regulate distinct cellular processes
DOCK180 and EGFR are necessary for Rac activation downstream
of junction assembly (Figs. 1 and 3). Yet, although DOCK180 is recruited
to E-cadherin clusters in the absence of EGFR, it is feasible that EGFR
signalling could activate DOCK180 locally. If the latter process occurs,
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RNAi (D). Beads were added onto cells for 30 min, washed and stained for endogenous DOCK180. E, GST–E-cadherin tail beads were incubated with keratinocyte lysates prepared after a
time course of junction induction. Precipitates were probedwith anti-DOCK180 antibody (D180); fusion proteins are shown by Comassie Blue (C.B.). F, Following depletion of EGFR, cells
were induced to assemble contacts for 15 min and processed as described in E.
1910 J.C. Erasmus et al. / Cellular Signalling 27 (2015) 1905–1913one prediction is that DOCK180 and EGFR should contribute to the
regulation of similar cellular events during junction stabilisation.
We investigated the above point further and testedwhetherDOCK180
and EGFR are both necessary for actin recruitment to cadherin clus-
ters (Fig. 5), a process that is inhibited by dominant-negative Rac inkeratinocytes [23]. Similarly to Rac inhibition, EGFR RNAi caused a
partial, but signiﬁcant reduction of cadherin-dependent actin recruit-
ment (Fig. 5A–B). Strikingly, actin recruitment to clustered cadherin
receptors was not perturbed by DOCK180 depletion (Fig. 5A–B). These
results suggest that, following junction assembly, DOCK180may regulate
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1911J.C. Erasmus et al. / Cellular Signalling 27 (2015) 1905–1913alternative Rac functions other than actin remodelling. In contrast,
EGFR seems to be upstream of Rac in driving actin recruitment to
junctions.The question raised by the above experiments is, if actin recruitment
occurs independently of DOCK180 function, does DOCK180 indeed
stabilise E-cadherin contacts? Depletion of DOCK180 did not alter the
1912 J.C. Erasmus et al. / Cellular Signalling 27 (2015) 1905–1913levels of E-cadherin at newly-formed junctions after 30 min (Fig. S2).
This phenotype is clearly distinct from fragmented junctions observed
following EGFR RNAi (Fig. 2) or the pattern of junction disruption previ-
ously reported inMDCK cells [7]. While the localization of E-cadherin at
junctions is not perturbed, we tested whether junctions had similar
functionality in the absence of DOCK180. The speciﬁc aspectwe investi-
gated was resistance of cell aggregates to mechanical stress. Consistent
with our above results, upon DOCK180 depletion, formation of aggre-
gates in hanging drops was not perturbed (Fig. 5C, 120 min). However,
upon trituration of pre-formed aggregates, the remaining aggregates in
DOCK180-depleted keratinocytes were 30–40% smaller than controls
(Fig. 5C–E). In contrast, SOS1 depletion had no effect on aggregate
formation or stability (Fig. 5F–H). Our results suggest that DOCK180
is not necessary for assembly of cell–cell contacts, but previously formed
contacts are more fragile during mechanical stress.
4. Discussion
We present strong evidence of two pathways via which junctions
can activate Rac in keratinocytes: EGFR and DOCK180. Perturbing the
function of either protein by RNAi prevented junction-dependent Rac
activation. In spite of this similar phenotype and the role of DOCK180
downstream of EGFR signalling during migration, our data indicate
that DOCK180 and EGFR deploy distinct mechanisms to modulate
keratinocyte cell–cell adhesion. We surmise that, in the same cell type,
different GEFs are necessary for the repertoire of Rac functions that
collectively stabilise E-cadherin at junctions.
We speculated that co-clustering of EGFR and E-cadherin at junc-
tions [13] could trigger speciﬁc signalling to activate Rac locally. In
the absence of EGFR, Rac cannot be activated by junction assembly, a
phenotype that is not observed following ErbB3 RNAi. This result is
consistent with our ﬁndings that EGFR is the only family member able
to co-precipitate with E-cadherin. Although both EGFR and ErbB3 are
known to activate Rac upon ligand binding, our data demonstrate that,
downstream of E-cadherin engagement, the activation of Rac is speciﬁ-
cally EGFR-dependent.
To identify potential Rac regulators thatmediate the above responses,
DOCK180 and SOS1 were investigated because of their in vitro ability
to activate Rac and their participation in growth factor receptor signal-
ling pathways. Similar to EGFR, depletion of DOCK180, but not SOS1,
also prevents Rac activation by newly formed junctions. The involve-
ment of DOCK180 in the cadherin–Rac interplay is consistent with our
current thinking [3] that a speciﬁc stimulus will selectively engage a
particular GEF at junctions to drive Rac activation locally and regulate a
speciﬁc cellular event. The GEF selectivity guided by different stimuli
would thus enable tight spatial and temporal control of Rac activation
by speciﬁc molecular players.
DOCK180 appears to be associated with E-cadherin cytoplasmic tail
at steady state and thus further enrichment of DOCK180 at keratinocyte
cell–cell contacts occurs independently of EGFR. There is a formal possi-
bility that, once DOCK180 is at cell–cell contacts, it could be activated
indirectly by EGFR, and thus regulate some, but not all EGFR-dependent
phenotypes. For example, growth factor receptor-dependent phosphory-
lation has been shown for DOCK180 phosphorylation by EGFRvIII in
glioblastoma cells [28] or DOCK7 by ErbB2–ErbB3 heterodimers in
Schwann cells [29].
However, while both EGFR and DOCK180 are required for cadherin-
dependent Rac activation,we think it is unlikely that DOCK180 operates
downstreamof EGFR in the context of E-cadherin stabilisation. First, the
defects on cell–cell contacts caused by depletion of either protein differ
considerably. EGFRRNAi leads to junction fragmentation,while reduced
levels of DOCK180 do not interfere with E-cadherin distribution to new
adhesion sites. Yet, DOCK180 is important to provide resistance of
keratinocyte aggregates to mechanical stress.
Second, mechanistically, EGFR partially regulates actin recruitment
to clustered E-cadherin complexes. Surprisingly, DOCK180 does notseem to participate in this process, even though it is well established
that actin remodelling at junctions requires Rac function [2,3,30]. It is
feasible that the protection to mechanical stress at junctions provided
byDOCK180may involve alternative functions of Rac, such as regulation
of contraction or reinforcement of contacts by trafﬁcking.
Third, GEF recruitment to and residence at junctions may differ de-
pending on the cell type. In MDCK cells, DOCK180 transiently accumu-
lates at early contacts [7], while in keratinocytes, DOCK180 remains
associated with cadherin complexes for up to 30 min of junction induc-
tion. At this time point in keratinocytes, the cadherin recruitment to
junctions, cytoskeletal remodelling and polarization are mostly accom-
plished [26,31]. The distinct pattern of DOCK180 recruitment between
MDCK and keratinocytes suggests a differential regulation according
to the cellular context. The latter is also reﬂected on the distinct out-
come of DOCK180 depletion: inhibition of cadherin localization at
early junctions is observed in MDCK [7], but not in keratinocytes (this
work). We surmise that, upon contact initiation, distinct signalling,
kinetics andmembrane dynamicsmay account for the regulatory differ-
ences among cell types.
Clearly, further work is necessary to deﬁne mechanistically how
junction assembly recruits and regulates DOCK180 in keratinocytes
and the potential impact on the modulation of resistance of junctions
to mechanical stress. Our results are in agreement with the ability of
a distinct DOCK180 family member, DOCK3, to regulate cell–cell adhe-
sion (also known as Modiﬁer of Cell Adhesion or MOCA). Expression
of DOCK3 increases aggregation of neuronal cell lines speciﬁcally
via N-cadherin, but not E-cadherin [32]. DOCK3 up-regulation of
N-cadherin levels may regulate the cadherin switch programme during
tumour progression [33] and correlates with increased tumour inva-
siveness in head and neck tumour patients [34].
5. Conclusions
We uncover here two distinct pathways ways via which Rac can be
activated by junctions in the same cell type, and their different cellular
outcomes to enable stable adhesion. EGFR is the only family member
able to initiate Rac signalling downstream of E-cadherin. Although
DOCK180 shares this abilitywith EGFR, thesemolecules regulate distinct
Rac-dependent processes: resistance to mechanical stress and actin
recruitment to cadherin clusters, respectively. Thus, DOCK180 is unlikely
to operate downstream of EGFR signalling triggered by junctions. We
demonstrate a direct role of DOCK180 in Rac activation and the me-
chanical support of cadherinmature contacts. Finally, our data strengthen
the notion that DOCK family members emerge as master regulators of
cell–cell adhesion events in different cellular contexts.
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